Key result
Recombinant ACE2 improves oxygenation and attenuates pulmonary hypertension vs saline in experimental ARDS.
Why the study?
Acute respiratory distress syndrome carries a high mortality rate with no specific therapy to improve clinical outcomes. Although angiotensin-converting enzyme 2 ameliorates acute lung injury in mice, its therapeutic potential had yet to be evaluated in a piglet model allowing assessment of intensive care monitoring parameters.
Does recombinant angiotensin-converting enzyme 2 improve pulmonary hemodynamics and oxygenation in a piglet model of acute respiratory distress syndrome?
RCT (n=15)
Double-blind
Randomized
No
Does recombinant angiotensin-converting enzyme 2 improve pulmonary hemodynamics and oxygenation in a piglet model of acute respiratory distress syndrome?
Recombinant ACE2 attenuates arterial hypoxemia and pulmonary hypertension in a piglet model of ARDS, suggesting potential therapeutic utility.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for recombinant ACE2 in ARDS; human trials needed before clinical consideration.
Objective To study angiotensin-converting enzyme 2 in a piglet model with acute respiratory distress syndrome and to evaluate the therapeutic potential of this substance in a preclinical setting, as this model allows the assessment of the same parameters required for monitoring the disease in human intensive care medicine. The acute respiratory distress syndrome is the most severe form of acute lung injury with a high mortality rate. As yet, there is no specific therapy for improving the clinical outcome. Recently, angiotensin-converting enzyme 2, which inactivates angiotensin II, has been shown to ameliorate acute lung injury in mice. Design Prospective, randomized, double-blinded animal study. Setting Animal research laboratory. Subjects Fifteen anesthetized and mechanically ventilated piglets. Interventions Acute respiratory distress syndrome was induced by lipopolysaccharide infusion. Thereafter, six animals were assigned randomly into angiotensin-converting enzyme 2 group, whereas another six animals served as control. Three animals received angiotensin-converting enzyme 2 without lipopolysaccharide pretreatment. Measurements and main results Systemic and pulmonary hemodynamics, blood gas exchange parameters, tumor necrosis factor-alpha, and angiotensin II levels were examined before acute respiratory distress syndrome induction and at various time points after administering angiotensin-converting enzyme 2 or saline. In addition, ventilation-perfusion distribution of the lung tissue was assessed by the multiple inert gas elimination technique. Animals treated with angiotensin-converting enzyme 2 maintained significantly higher PaO2 than the control group, and pulmonary hypertension was less pronounced. Furthermore, angiotensin II and tumor necrosis factor-alpha levels, both of which were substantially increased, returned to basal values. Multiple inert gas elimination technique revealed a more homogeneous pulmonary blood flow after treatment with angiotensin-converting enzyme 2. In intergroup comparisons, there were no differences in pulmonary blood flow to lung units with subnormal ventilation/perfusion ratios. Conclusions Angiotensin-converting enzyme 2 attenuates arterial hypoxemia, pulmonary hypertension, and redistribution of pulmonary blood flow in a piglet model of acute respiratory distress syndrome, and may be a promising substance for clinical use.
No takes yet. Share an insight, caveat, or question.
Treml et al. (2010) conducted an RCT in Lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) (n=15). Recombinant angiotensin-converting enzyme 2 (ACE2) vs. Saline control was evaluated on Systemic and pulmonary hemodynamics, blood gas exchange parameters (PaO2), ventilation-perfusion distribution, and TNF-alpha and angiotensin II levels. Recombinant ACE2 significantly improved PaO2, attenuated pulmonary hypertension, and normalized angiotensin II and TNF-alpha levels vs saline control in piglets with LPS-induced ARDS (n=15).
Synapse has enriched 10 related papers. Consider them for comparative context: